Beatriz Gros
@bealoquebea.bsky.social
Gastroenterologist #IBD specialist
Help others grow their abilities and celebreate life. 🆓 IBD education https://ibd-eii.com/ @WHO.fides member
Help others grow their abilities and celebreate life. 🆓 IBD education https://ibd-eii.com/ @WHO.fides member
Grateful to have worked with this amazing team on this project!
To curb the rapid rise of #IBD, we must understand both risk & protective factors
Our latest research explores key environmental influences to guide prevention strategies
academic.oup.com/ecco-jcc/adv...
To curb the rapid rise of #IBD, we must understand both risk & protective factors
Our latest research explores key environmental influences to guide prevention strategies
academic.oup.com/ecco-jcc/adv...
March 11, 2025 at 3:08 PM
Grateful to have worked with this amazing team on this project!
To curb the rapid rise of #IBD, we must understand both risk & protective factors
Our latest research explores key environmental influences to guide prevention strategies
academic.oup.com/ecco-jcc/adv...
To curb the rapid rise of #IBD, we must understand both risk & protective factors
Our latest research explores key environmental influences to guide prevention strategies
academic.oup.com/ecco-jcc/adv...
Time turns people into legends
1/🧵 on one of the most important women in med history: Gertrude B. Elion
You may not know her, but her discoveries changed medicine
She co-developed thiopurines (azathioprine, mercaptopurine), a breakthrough in immunosuppressive therapy, & won the Nobel Prize in 1988
1/🧵 on one of the most important women in med history: Gertrude B. Elion
You may not know her, but her discoveries changed medicine
She co-developed thiopurines (azathioprine, mercaptopurine), a breakthrough in immunosuppressive therapy, & won the Nobel Prize in 1988
March 8, 2025 at 3:08 PM
Time turns people into legends
1/🧵 on one of the most important women in med history: Gertrude B. Elion
You may not know her, but her discoveries changed medicine
She co-developed thiopurines (azathioprine, mercaptopurine), a breakthrough in immunosuppressive therapy, & won the Nobel Prize in 1988
1/🧵 on one of the most important women in med history: Gertrude B. Elion
You may not know her, but her discoveries changed medicine
She co-developed thiopurines (azathioprine, mercaptopurine), a breakthrough in immunosuppressive therapy, & won the Nobel Prize in 1988
🔎Strictures in Crohn's disease can be challenging to manage
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
March 1, 2025 at 12:46 PM
🔎Strictures in Crohn's disease can be challenging to manage
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
🔎Strictures in Crohn's disease can be challenging to manage
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
March 1, 2025 at 11:56 AM
🔎Strictures in Crohn's disease can be challenging to manage
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
I've put together a summary on different approaches and an infographic on strictureplasties
Patients want to know about this, so I hope this can serve as an useful resource
🆕www.ibd-eii.com/ibdcheatsheet
#IBD
Wrapping up February with the latest updates on www.ibd-eii.com !
This month's newsletter, coming this evening, includes new triss and #IBD cheatsheets!
Some interesting research, like this one on hemorrhoid therapy in IBD (📷).
Stay tuned!
This month's newsletter, coming this evening, includes new triss and #IBD cheatsheets!
Some interesting research, like this one on hemorrhoid therapy in IBD (📷).
Stay tuned!
February 28, 2025 at 7:37 PM
Wrapping up February with the latest updates on www.ibd-eii.com !
This month's newsletter, coming this evening, includes new triss and #IBD cheatsheets!
Some interesting research, like this one on hemorrhoid therapy in IBD (📷).
Stay tuned!
This month's newsletter, coming this evening, includes new triss and #IBD cheatsheets!
Some interesting research, like this one on hemorrhoid therapy in IBD (📷).
Stay tuned!
Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies
Our latest publication
www.mdpi.com/2077-0383/14...
Our latest publication
www.mdpi.com/2077-0383/14...
February 25, 2025 at 8:50 PM
Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies
Our latest publication
www.mdpi.com/2077-0383/14...
Our latest publication
www.mdpi.com/2077-0383/14...
REScUE trial of patients with CD losing response to UST
All patients received IV reinduction and then q4w SC vs q8w SC
❗️Primary outcome: SF clinical remission: PRO2 & FCP <250 & no steroids for 90 days before w48
‼️Less than 20% met primary outcome
#ECCO2025
All patients received IV reinduction and then q4w SC vs q8w SC
❗️Primary outcome: SF clinical remission: PRO2 & FCP <250 & no steroids for 90 days before w48
‼️Less than 20% met primary outcome
#ECCO2025
February 22, 2025 at 8:17 PM
REScUE trial of patients with CD losing response to UST
All patients received IV reinduction and then q4w SC vs q8w SC
❗️Primary outcome: SF clinical remission: PRO2 & FCP <250 & no steroids for 90 days before w48
‼️Less than 20% met primary outcome
#ECCO2025
All patients received IV reinduction and then q4w SC vs q8w SC
❗️Primary outcome: SF clinical remission: PRO2 & FCP <250 & no steroids for 90 days before w48
‼️Less than 20% met primary outcome
#ECCO2025
Clusters of antibiotic use patterns after the first episode of pouchitis
4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent
antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis
#ECCO2025
4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent
antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis
#ECCO2025
February 22, 2025 at 7:58 PM
Clusters of antibiotic use patterns after the first episode of pouchitis
4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent
antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis
#ECCO2025
4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent
antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis
#ECCO2025
Phase 1b study of SOR102, orally delivered bispecific anti-TNF/anti-IL-23 domain antibody in mild to
severe UC
!! Phase 1b very small N so caution with interpretation
It surprised me the fact that it includes also patients with mild #UC? giving a double acting
#IBD #ECCO2025
severe UC
!! Phase 1b very small N so caution with interpretation
It surprised me the fact that it includes also patients with mild #UC? giving a double acting
#IBD #ECCO2025
February 22, 2025 at 7:43 PM
Very nice tandem of
@Iris_Dotan
and Revital Barkan about how far should we pursue our targets to help patients live a normal life?
✅How fast should we act? FASTER & FURTHER
✅Stratify patients better
✅Multidisciplinary approach
🌍Address community gaps
@Iris_Dotan
and Revital Barkan about how far should we pursue our targets to help patients live a normal life?
✅How fast should we act? FASTER & FURTHER
✅Stratify patients better
✅Multidisciplinary approach
🌍Address community gaps
February 22, 2025 at 7:30 PM
Very nice tandem of
@Iris_Dotan
and Revital Barkan about how far should we pursue our targets to help patients live a normal life?
✅How fast should we act? FASTER & FURTHER
✅Stratify patients better
✅Multidisciplinary approach
🌍Address community gaps
@Iris_Dotan
and Revital Barkan about how far should we pursue our targets to help patients live a normal life?
✅How fast should we act? FASTER & FURTHER
✅Stratify patients better
✅Multidisciplinary approach
🌍Address community gaps
And the data in UC
February 22, 2025 at 7:15 PM
And the data in UC
February 22, 2025 at 7:13 PM
None better than @ibdseb.bsky.social to talk about underrepresented populations in #IBD research #ECCO2025
Difficult to choose the best slides, thanks Seb
Difficult to choose the best slides, thanks Seb
February 19, 2025 at 10:21 AM
None better than @ibdseb.bsky.social to talk about underrepresented populations in #IBD research #ECCO2025
Difficult to choose the best slides, thanks Seb
Difficult to choose the best slides, thanks Seb
February 19, 2025 at 10:01 AM
February 19, 2025 at 9:57 AM
Two years ago,I had a crazy idea
I want to say thank you to everyone who saw a young girl believing in herself and chose to believe in her too
📈390k visits & more than 39k users.Reminder that science knows NO borders & we are all connected by the same passion & mission:to help others
#ibd
I want to say thank you to everyone who saw a young girl believing in herself and chose to believe in her too
📈390k visits & more than 39k users.Reminder that science knows NO borders & we are all connected by the same passion & mission:to help others
#ibd
February 9, 2025 at 5:24 PM
Two years ago,I had a crazy idea
I want to say thank you to everyone who saw a young girl believing in herself and chose to believe in her too
📈390k visits & more than 39k users.Reminder that science knows NO borders & we are all connected by the same passion & mission:to help others
#ibd
I want to say thank you to everyone who saw a young girl believing in herself and chose to believe in her too
📈390k visits & more than 39k users.Reminder that science knows NO borders & we are all connected by the same passion & mission:to help others
#ibd
Meeting Brigida Barbeiro, someone I have admired for years for her work in #IBD thanks to @myueg.bsky.social
February 3, 2025 at 1:03 PM
Meeting Brigida Barbeiro, someone I have admired for years for her work in #IBD thanks to @myueg.bsky.social
With the recent approval of mirikizumab for #Crohnsdisease and guselkumab for #UC, I’ve updated the tables on the website 📊
Thanks to one of your suggestions,they now include the update date 📅 I appreciate your help in improving the content! 🔗 www.ibd-eii.com/ibdcheatsheet
#IBD #ulcerativecolitis
Thanks to one of your suggestions,they now include the update date 📅 I appreciate your help in improving the content! 🔗 www.ibd-eii.com/ibdcheatsheet
#IBD #ulcerativecolitis
February 2, 2025 at 11:43 AM
With the recent approval of mirikizumab for #Crohnsdisease and guselkumab for #UC, I’ve updated the tables on the website 📊
Thanks to one of your suggestions,they now include the update date 📅 I appreciate your help in improving the content! 🔗 www.ibd-eii.com/ibdcheatsheet
#IBD #ulcerativecolitis
Thanks to one of your suggestions,they now include the update date 📅 I appreciate your help in improving the content! 🔗 www.ibd-eii.com/ibdcheatsheet
#IBD #ulcerativecolitis
Understanding the complexity of chronic illnesses is no easy task
I created this figure with insights from patients to shed light on the multidimensional aspects of IBD.
Find the full-quality version on my website or in your inbox if you are subscribed—feel free to use it! 🌟
I created this figure with insights from patients to shed light on the multidimensional aspects of IBD.
Find the full-quality version on my website or in your inbox if you are subscribed—feel free to use it! 🌟
January 28, 2025 at 2:51 PM
Understanding the complexity of chronic illnesses is no easy task
I created this figure with insights from patients to shed light on the multidimensional aspects of IBD.
Find the full-quality version on my website or in your inbox if you are subscribed—feel free to use it! 🌟
I created this figure with insights from patients to shed light on the multidimensional aspects of IBD.
Find the full-quality version on my website or in your inbox if you are subscribed—feel free to use it! 🌟
It's hard to believe, www.ibd-eii.com is about to turn 2️⃣years old
Next week, I'll send out the pre-anniversary email, with new summaries like this one
Thank you for your support and for keeping me motivated
If you want to subscribe Just 1 📩totally free #IBD
Next week, I'll send out the pre-anniversary email, with new summaries like this one
Thank you for your support and for keeping me motivated
If you want to subscribe Just 1 📩totally free #IBD
January 26, 2025 at 12:11 PM
It's hard to believe, www.ibd-eii.com is about to turn 2️⃣years old
Next week, I'll send out the pre-anniversary email, with new summaries like this one
Thank you for your support and for keeping me motivated
If you want to subscribe Just 1 📩totally free #IBD
Next week, I'll send out the pre-anniversary email, with new summaries like this one
Thank you for your support and for keeping me motivated
If you want to subscribe Just 1 📩totally free #IBD
Here with Lumir and @anadugic.bsky.social thrilled to collaborate shaping UEG education
January 24, 2025 at 11:14 AM
Here with Lumir and @anadugic.bsky.social thrilled to collaborate shaping UEG education
VEDOKIDS Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease just published
✅ At w54 47% UC/IBDU in clinical remission and 24% of CD
🌟 More studies to prove safety & efficacy in pediatric population needed
www.sciencedirect.com/science/arti...
@thelancet.bsky.social
✅ At w54 47% UC/IBDU in clinical remission and 24% of CD
🌟 More studies to prove safety & efficacy in pediatric population needed
www.sciencedirect.com/science/arti...
@thelancet.bsky.social
January 9, 2025 at 6:20 AM
VEDOKIDS Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease just published
✅ At w54 47% UC/IBDU in clinical remission and 24% of CD
🌟 More studies to prove safety & efficacy in pediatric population needed
www.sciencedirect.com/science/arti...
@thelancet.bsky.social
✅ At w54 47% UC/IBDU in clinical remission and 24% of CD
🌟 More studies to prove safety & efficacy in pediatric population needed
www.sciencedirect.com/science/arti...
@thelancet.bsky.social